Skip to content

Clinical trials

Completed Stomach Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Status: Completed Country / region: Australia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20081
20092
20102
20123
20131
20142
20153
20162
20172
20186
20192
20201
20211
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Amgen2
BeiGene2
Bristol-Myers Squibb2
AbbVie1
Ambrx, Inc.1
Arbele Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms38
Carcinoma, Non-Small-Cell Lung8
Colorectal Neoplasms8
Ovarian Neoplasms7
Breast Neoplasms6
Cholangiocarcinoma5
Triple Negative Breast Neoplasms5
Esophageal Neoplasms4
Melanoma4
Neoplasm Metastasis4

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.